Please login to the form below

Not currently logged in
Email:
Password:

genomes

This page shows the latest genomes news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Brexit reshuffle brings new health minister, Celgene thalassemia success, Wellcome read to leap into future

Daily Brief: Brexit reshuffle brings new health minister, Celgene thalassemia success, Wellcome read to leap into future

The Leap Fund aims to foster breakthroughs on a par with dazzling innovations such as the cryro-electron microscopy, and nanopore genome sequencing, but aims to accelerate the rate at which

Latest news

More from news
Approximately 6 fully matching, plus 155 partially matching documents found.

Latest Intelligence

  • Can new data aggregators shift the balance of power away from pharma? Can new data aggregators shift the balance of power away from pharma?

    However, it was only 20 years ago that several genomics companies, led by Human Genome Sciences Inc, thought they could secure a monopoly position over unprecedented drug targets by filing patents ... on gene sequences emerging from their own human

  • 30 Women Leaders in UK Healthcare

    100, 000 Genomes Project. ... It represents the world’s largest depository of whole genomes with associated clinical data, and is already being used to diagnose and personalise treatment for people with rare diseases and cancers.

  • Integrating digital biomarkers into precision medicine Integrating digital biomarkers into precision medicine

    In many ways, this model parallels traditional biomarker development where, for example, blood samples can be collected early in clinical research to then support genome-wide association studies to detect genetic

  • Avoiding data pitfalls in clinical research Avoiding data pitfalls in clinical research

    This is a deceptively difficult task, but once patient IDs are matched within the clinical trial database, researchers have access to an analytical environment that ties together the entire genome, adverse ... With the terabytes and petabytes of data

  • Reactivating drug research programmes Reactivating drug research programmes

    One research-led breakthrough to hit the headlines involves the use of genome sequencing to isolate different strains of tuberculosis (TB), allowing the disease to be diagnosed more quickly. ... Just a decade ago, it would have cost many millions of

More from intelligence
Approximately 1 fully matching, plus 24 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics